Rokit Healthcare Inc
KOSDAQ:376900
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rokit Healthcare Inc
KOSDAQ:376900
|
KR |
Bankruptcy Probability
Rokit Healthcare Inc's probability of bankruptcy is 3.8%, pointing to a small but noticeable default risk. The solvency score is 44/100 — a warning sign of potential financial weakness.
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Financial Position
| Mar 31, 2026 | 78.9B |
| Dec 31, 2025 | 32.1B |
| Sep 30, 2025 | 35.7B |
| Jun 30, 2025 | 11.5B |
| Mar 31, 2026 | 10.5B |
| Dec 31, 2025 | 497m |
| Sep 30, 2025 | -400 |
| Jun 30, 2025 | 200 |
| Mar 31, 2026 | 3.8B |
| Dec 31, 2025 | 4.1B |
| Sep 30, 2025 | 4.3B |
| Jun 30, 2025 | 4.8B |
Solvency Ratios
Solvency Ratios Comparison
Rokit Healthcare Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
R
|
Rokit Healthcare Inc
KOSDAQ:376900
|
427.7B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Rokit Healthcare Inc's probability of bankruptcy is 3.7%, pointing to a small but noticeable default risk.
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Rokit Healthcare Inc has total debt of 3.8B KRW. This includes both short-term (3.7B KRW) and long-term (133.2m KRW) debt.
You can find a full breakdown on its Balance Sheet.
